Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation

Abstract Transjugular intrahepatic portosystemic shunt (TIPS) is one of the main treatment options in patients with decompensated liver cirrhosis but is still associated with partly severe complications. For adequate patient selection, prognostic parameters are of crucial importance. The liver maxim...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jassin Rashidi-Alavijeh, Alisan Kahraman, Guido Gerken, Jens M. Theysohn, Katharina Willuweit, Dieter P. Hoyer, Christian M. Lange, Matthias Buechter
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7973f874b0824f02874e33ed5c01fcc6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7973f874b0824f02874e33ed5c01fcc6
record_format dspace
spelling oai:doaj.org-article:7973f874b0824f02874e33ed5c01fcc62021-12-02T15:23:07ZEnzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation10.1038/s41598-021-93392-52045-2322https://doaj.org/article/7973f874b0824f02874e33ed5c01fcc62021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-93392-5https://doaj.org/toc/2045-2322Abstract Transjugular intrahepatic portosystemic shunt (TIPS) is one of the main treatment options in patients with decompensated liver cirrhosis but is still associated with partly severe complications. For adequate patient selection, prognostic parameters are of crucial importance. The liver maximum capacity (LiMAx) breath test measures enzymatic liver function and could potentially represent an efficient prognostic marker. We therefore aimed to assess the role of LiMAx in predicting survival of TIPS patients in a prospective analysis. LiMAx was performed for patients who underwent TIPS implantation between October 2016 and February 2018. Associations with transplant-free survival after 24 weeks were assessed by logistic regression. A total number of 30 patients were included, of whom seven received liver transplantation (N = 2) or died (N = 5) during follow-up. LiMAx values after (P = 0.01, OR = 1.24, 95% CI = 1.04–1.47) and before (P = 0.03, OR 1.21, 95% CI = 1.02–1.43) TIPS implantation and MELD score (P = 0.03, OR = 0.79, 95% CI = 0.63–0.98) were significantly associated with transplant-free survival according to univariate logistic regression. In AUROC analysis, LiMAx at day one after TIPS (sensitivity 85.7%, specificity 78.3%, AUROC 0.85, cut-off ≤ 165 µg/kg/h), LiMAx value at the day before TIPS (sensitivity 100%, specificity 73.9%, AUROC 0.82, cut-off ≤ 205 µg/kg/h) and MELD score (sensitivity 71.4%, specificity 73.9%, AUROC 0.82, cut-off ≥ 15) had the highest prognostic accuracy. LiMAx values prior and after TIPS procedure seem to be good prognostic parameters regarding prediction of transplant-free survival of patients undergoing TIPS implantation.Jassin Rashidi-AlavijehAlisan KahramanGuido GerkenJens M. TheysohnKatharina WilluweitDieter P. HoyerChristian M. LangeMatthias BuechterNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jassin Rashidi-Alavijeh
Alisan Kahraman
Guido Gerken
Jens M. Theysohn
Katharina Willuweit
Dieter P. Hoyer
Christian M. Lange
Matthias Buechter
Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation
description Abstract Transjugular intrahepatic portosystemic shunt (TIPS) is one of the main treatment options in patients with decompensated liver cirrhosis but is still associated with partly severe complications. For adequate patient selection, prognostic parameters are of crucial importance. The liver maximum capacity (LiMAx) breath test measures enzymatic liver function and could potentially represent an efficient prognostic marker. We therefore aimed to assess the role of LiMAx in predicting survival of TIPS patients in a prospective analysis. LiMAx was performed for patients who underwent TIPS implantation between October 2016 and February 2018. Associations with transplant-free survival after 24 weeks were assessed by logistic regression. A total number of 30 patients were included, of whom seven received liver transplantation (N = 2) or died (N = 5) during follow-up. LiMAx values after (P = 0.01, OR = 1.24, 95% CI = 1.04–1.47) and before (P = 0.03, OR 1.21, 95% CI = 1.02–1.43) TIPS implantation and MELD score (P = 0.03, OR = 0.79, 95% CI = 0.63–0.98) were significantly associated with transplant-free survival according to univariate logistic regression. In AUROC analysis, LiMAx at day one after TIPS (sensitivity 85.7%, specificity 78.3%, AUROC 0.85, cut-off ≤ 165 µg/kg/h), LiMAx value at the day before TIPS (sensitivity 100%, specificity 73.9%, AUROC 0.82, cut-off ≤ 205 µg/kg/h) and MELD score (sensitivity 71.4%, specificity 73.9%, AUROC 0.82, cut-off ≥ 15) had the highest prognostic accuracy. LiMAx values prior and after TIPS procedure seem to be good prognostic parameters regarding prediction of transplant-free survival of patients undergoing TIPS implantation.
format article
author Jassin Rashidi-Alavijeh
Alisan Kahraman
Guido Gerken
Jens M. Theysohn
Katharina Willuweit
Dieter P. Hoyer
Christian M. Lange
Matthias Buechter
author_facet Jassin Rashidi-Alavijeh
Alisan Kahraman
Guido Gerken
Jens M. Theysohn
Katharina Willuweit
Dieter P. Hoyer
Christian M. Lange
Matthias Buechter
author_sort Jassin Rashidi-Alavijeh
title Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation
title_short Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation
title_full Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation
title_fullStr Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation
title_full_unstemmed Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation
title_sort enzymatic liver function measured by limax is superior to current standard methods in predicting transplant-free survival after tips implantation
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/7973f874b0824f02874e33ed5c01fcc6
work_keys_str_mv AT jassinrashidialavijeh enzymaticliverfunctionmeasuredbylimaxissuperiortocurrentstandardmethodsinpredictingtransplantfreesurvivalaftertipsimplantation
AT alisankahraman enzymaticliverfunctionmeasuredbylimaxissuperiortocurrentstandardmethodsinpredictingtransplantfreesurvivalaftertipsimplantation
AT guidogerken enzymaticliverfunctionmeasuredbylimaxissuperiortocurrentstandardmethodsinpredictingtransplantfreesurvivalaftertipsimplantation
AT jensmtheysohn enzymaticliverfunctionmeasuredbylimaxissuperiortocurrentstandardmethodsinpredictingtransplantfreesurvivalaftertipsimplantation
AT katharinawilluweit enzymaticliverfunctionmeasuredbylimaxissuperiortocurrentstandardmethodsinpredictingtransplantfreesurvivalaftertipsimplantation
AT dieterphoyer enzymaticliverfunctionmeasuredbylimaxissuperiortocurrentstandardmethodsinpredictingtransplantfreesurvivalaftertipsimplantation
AT christianmlange enzymaticliverfunctionmeasuredbylimaxissuperiortocurrentstandardmethodsinpredictingtransplantfreesurvivalaftertipsimplantation
AT matthiasbuechter enzymaticliverfunctionmeasuredbylimaxissuperiortocurrentstandardmethodsinpredictingtransplantfreesurvivalaftertipsimplantation
_version_ 1718387333133238272